Close

Theravance Biopharma (TBPH), Mylan (MYL) Announce New Data from Phase 3 Studies of YUPELRI (revefenacin) at ERS Congres 2018

September 17, 2018 8:32 AM EDT Send to a Friend
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced that positive new data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login